Epigallo Catechin Gallate

DB16120InvestigationalSmall molecule

Epigallo Catechin Gallate is under investigation in clinical trial NCT00799890 (Sunphenon in Progressive Forms of Multiple Sclerosis).

Mechanism: Pharmacologically active on Pancreatic triacylglycerol lipase, Aldo-keto reductase family 1 member B1, and Caspase-3
Curator reviewed
Formula / weight: C₂₂H₁₈O₁₀ · 442.376 g/mol (avg)
Also known as: (+)-catechin 3-gallate · (+)-catechin gallate · Catechin Gallate · Catechin gallate, (+)-

Resolves to

Compound

Structure

InChIKeyLSHVYAFMTMFKBA-PZJWPPBQSA-NSMILESOC1=CC2=C(C[C@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](O2)C2=CC(O)=C(O)C=C2)C(O)=C1

Targets

What you can answer from here — as of July 08, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Epigallo Catechin Gallate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.